2024 Events

Join us at one of our 2024 community events

42nd Annual J.P. Morgan Healthcare Conference San Francisco, CA 8-11 Jan 2024

The J.P Morgan Health Care Conference connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

We are excited to be discussing how Phesi’s unique patient-centric platform and AI technology is transforming clinical development.

SCOPE Rosen shingle creek, Orlando, FL 11-14 Feb 2024

Come and talk to us about how we can help you optimize protocol design, country and investigator site performance with Trial Accelerator at booth 1021.

See how our Trial Accelerator™ platform can simulate your clinical trials and generate Digital Patient Profiles to inform your protocol design and improve country and investigator site performance.

CMOS Fairmont Copley Plaza, Boston, MA 17 - 18 Apr 2024

Join us at the largest gathering of biotech Chief Medical Officers across indications, modalities, company stages, professional experience levels and geographic locations. Discover how collaboration can deliver greater precision, insight and certainty in clinical development.

ASCO McCormick Place, Chicago, IL May 31 - 4 Jun 2024

Join us for the world’s largest global oncology meeting known for shaping new standards of care and learn how oncology’s most powerful clinical development platform can help you deliver smarter trials and faster cures.

ESMO Barcelona 13 - 17 Sept 2024

Join us at the globally influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.

DPHARM Philadelphia 17-18 Sept 2024

Join us at the most advanced conference to modernize clinical research. In 2023 Phesi was a DPHARM Idol finalist – in 2024 we will be unveiling our latest disruptive innovations for modernizing clinical trials.

CNS Summit Boston November 2024

Join us at this collaborative industry event which brings together a curated group of top decision makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders.